November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...

"Oh, that's just from smoking." It's easy to dismiss a chronic cough as another problem with cigarettes. But what if it's a sign of the lung disease COPD? Franziska Gabbert/dpa Long-term smokers often ...

Chronic obstructive pulmonary disease (COPD) is the world’s third leading cause of death. Although often overlooked, it is still widespread, currently affecting around 391 million individuals ...

Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...

Chronic Obstructive Pulmonary Disease, known as COPD, is a common lung disease that makes it difficult to breathe. It is caused by damage to the lungs that blocks airflow and, over time, can lead to ...

Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will impact their patients. The ...

Mental health disorders in people with chronic obstructive pulmonary disease (COPD) are underdiagnosed and undertreated, leading to worsened symptoms and decreased quality of life, according to a new ...

The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...

Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for about three months, a new study has revealed. This research by The University ...